pillbase.ru

Empaveli

Active substance: pegcetacoplan

INJECTION, SOLUTION · PEGCETACOPLAN 1080 mg/20mL

United StatesActive

Marketing holder: Apellis Pharmaceuticals, Inc.

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
EU 2
  • Aspaveli
    pegcetacoplan
    EMEA/H/C/005553
    Swedish Orphan Biovitrum AB (publ)
  • Syfovre
    pegcetacoplan
    EMEA/H/C/005954
    Apellis Europe B.V.
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-2f03-7331-aef2-035d6c8fe029,01a12095-1da8-7af7-a25d-d51104657b2b;count=2 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
73606-010
Registration status
Active
Dispensing
Prescription only
Route
SUBCUTANEOUS
Sources
  • product · openFDA NDC · 73606-010 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 73606-010 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 73606-010 · Verified 2026-10-09 · open in source